Skip to main content
    O

    Omeros Corporation (OMER)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $16.68
    -0.81 (-4.63%)

    Market Cap: $1.27B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Omeros Corporation (OMER) Financials: Revenue, Profit and Cash Flow

    Updated Nov 16, 2026. Financial statements from company filings, amounts in US dollars.

    Omeros reported revenue of $0 for the fiscal year ended Dec 31, 2025. That year, net income was -$3.35M, operating cash flow was -$116.09M and free cash flow was -$116.16M. The quarter ended Sep 30, 2026 had revenue of $35.93M and net income of -$57.36M.

    Revenue and Margins

    The company reported no revenue in the fiscal year ended Dec 2025, with an operating loss of $122.80M.

    Fiscal yearRevenueGrowthGross marginOperating marginNet margin
    Dec 2025$0N/AN/AN/AN/A
    Dec 2024$0N/AN/AN/AN/A
    Dec 2023$0N/AN/AN/AN/A
    Dec 2022$0N/AN/AN/AN/A
    Dec 2021$0N/AN/AN/AN/A
    Dec 2020$0N/AN/AN/AN/A
    Dec 2019$0-100.0%N/AN/AN/A
    Dec 2018$29.87M-53.9%98.3%-375.7%-424.4%
    Dec 2017$64.83M+55.8%98.3%-67.7%-82.5%
    Dec 2016$41.62MN/A96.6%-130.4%-160.4%
    Annual, fiscal years ended Dec 2016 to Dec 2025

    Income Statement

    In the fiscal year ended Dec 2025, the net loss narrowed from the year before. In the quarter ended Sep 2026, the net loss widened from the same quarter a year earlier.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Revenue$0$0$0$0$0$0$0$29.87M$64.83M$41.62M
    Cost of revenue$0$0$0$0$0$0$0$512.00K$1.08M$1.41M
    Gross profit$0$0$0$0$0$0$0$29.36M$63.75M$40.20M
    Research and development$81.30M$119.52M$114.87M$112.72M$118.78M$107.61M$106.32M$89.86M$55.60M$50.70M
    Operating income-$122.80M-$166.95M-$164.53M-$163.39M-$173.62M-$156.92M-$146.04M-$112.22M-$43.90M-$54.28M
    Net income-$3.35M-$156.81M-$117.81M$47.42M$194.24M-$138.06M-$84.49M-$126.76M-$53.48M-$66.75M
    EBITDA-$28.17MN/A-$161.76M-$160.61M-$170.53M-$143.65M-$133.46M-$103.84M-$39.16M-$53.98M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Revenue$35.93M$28.53M$9.89M$0$0$0$0$0$0$0$0N/A
    Gross profit$35.11M$27.73M$9.31MN/A$0$0$0N/A$0$0$0N/A
    Operating income$4.50M$74.00K-$17.42M-$29.08M-$26.39M-$32.35M-$34.97M-$33.35M-$35.41M-$59.16M-$39.03M-$39.77M
    Net income-$57.36M$13.23M$56.06M$81.93M-$30.92M-$25.42M-$33.46M-$25.07M-$35.41M-$59.16M-$37.18M-$9.07M
    Last 12 quarters

    Balance Sheet

    As of Dec 2025, total debt of $68.43M exceeded cash and equivalents by $58.77M. Shareholder equity was negative, at -$121.23M, as total liabilities of $446.86M exceeded total assets of $325.63M.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Total assets$325.63M$277.08M$378.27M$590.97M$419.27M$181.04M$136.97M$95.94M$116.33M$67.28M
    Current assets$215.67M$134.12M$217.90M$443.24M$247.96M$151.28M$103.75M$89.87M$108.37M$60.26M
    Cash and equivalents$9.66M$3.40M$7.11M$11.01M$100.81M$10.50M$3.08M$5.86M$3.39M$2.22M
    Total liabilities$446.86M$459.69M$403.25M$505.29M$395.49M$301.79M$245.99M$196.09M$119.14M$104.72M
    Short-term debt$17.06M$21.00M$0$94.38M$0$3.78M$3.50M$889.00K$490.00K$198.00K
    Long-term debt$51.36M$166.82M$213.16M$220.91M$313.46M$236.29M$158.21M$148.98M$83.31M$79.51M
    Shareholder equity-$121.23M-$182.61M-$24.98M$85.68M$23.78M-$120.75M-$109.02M-$100.16M-$2.81M-$37.45M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Total assets$248.09M$286.83M$286.17M$325.63M$185.71M$200.57M$235.16M$277.08M$313.33M$356.31M$437.49M$378.27M
    Total liabilities$338.07M$338.18M$349.51M$446.86M$406.18M$429.25M$448.71M$459.69M$467.51M$480.91M$508.82M$403.25M
    Cash and equivalents$5.07M$1.99M$1.91M$9.66M$2.40M$1.90M$4.26M$3.40M$1.52M$2.12M$1.83M$7.11M
    Shareholder equity-$89.97M-$51.35M-$63.33M-$121.23M-$220.48M-$228.69M-$213.55M-$182.61M-$154.17M-$124.60M-$71.33M-$24.98M
    Last 12 quarters

    Cash Flow

    Operating cash flow was negative in the fiscal year ended Dec 2025.

    Annual

    Line itemDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016
    Operating cash flow-$116.09M-$148.80M$74.73M-$86.48M-$109.72M-$100.09M-$60.07M-$103.74M-$36.23M-$51.50M
    Capital expenditures$65.00K$165.00K$426.00K$113.00K$277.00K$283.00K$334.00K$567.00K$350.00K$126.00K
    Free cash flow-$116.16M-$148.97M$74.30M-$86.60M-$110.00M-$100.37M-$60.41M-$104.30M-$36.58M-$51.63M
    Share repurchases$0$11.85M$4.65M$0$241.00K$0$0N/AN/AN/A
    Investing cash flow$164.52M$82.22M$27.45M-$127.56M$193.71M-$67.03M-$3.40M$25.15M-$37.60M-$16.34M
    Financing cash flow-$42.17M$62.88M-$106.08M$124.25M$6.32M$174.53M$60.70M$81.05M$75.00M$68.70M
    Fiscal years ended Dec 2016 to Dec 2025

    Quarterly

    Line itemSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023
    Operating cash flow$13.26M$4.15M-$14.51M-$39.84M-$18.47M-$21.94M-$35.84M-$28.98M-$32.06M-$45.98M-$41.78M-$34.83M
    Capital expenditures$25.00K$45.00K$0$0$11.00K$13.00K$41.00K$26.00K$1.00K$80.00K$58.00K$118.00K
    Free cash flow$13.23M$4.10M-$14.51M-$39.84M-$18.48M-$21.95M-$35.88M-$29.01M-$32.06M-$46.06M-$41.84M-$34.94M
    Last 12 quarters

    Frequently Asked Questions About OMER

    What is Omeros' annual revenue?

    Omeros reported revenue of $0 for the fiscal year ended Dec 31, 2025.

    Is Omeros profitable?

    No. Omeros reported net income of -$3.35M for the fiscal year ended Dec 31, 2025.

    How much free cash flow does OMER generate?

    For the fiscal year ended Dec 31, 2025, operating cash flow of -$116.09M minus capital expenditures of $65.00K produced free cash flow of -$116.16M.

    How much debt does Omeros have?

    The balance sheet dated Dec 31, 2025 reported long-term debt of $51.36M, short-term debt of $17.06M and cash and equivalents of $9.66M.